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Adaptation to chronic hypoosmolality in rats. A method for maintain-
ing chronic severe hypoosmolality in rats is described utilizing subcu-
taneous infusions of the antidiuretic vasopressin analogue 1-deamino-
[8-D-arginine] vasopressin (DDAVP) at rates of 1 or 5 ng/hr via osmotic
minipumps in combination with self-ingestion of a concentrated, nutri-
tionally-balanced liquid diet. Using these methods, 97.3% of all rats
studied achieved stable levels of severe hyponatremia (plasma [Na1
111.6 0.5 mEq/liter, N = 213), which was sustained for periods of
time ranging from two to five weeks. Mortality was low (1.8%) and
observable morbidity was not noted over a series of studies encompass-
ing 4,628 rat days of sustained hypoosmolality. Analysis of food intake
and body weight revealed no evidence of tissue catabolism at any time
with the lower (1 ng/hr) DDAVP infusion rate, and only during the first
week with the higher (5 ng/hr) rate. Metabolic balance studies during 13
days of sustained hypoosmolality demonstrated the dilutional nature of
the hypoosmolality, and only a limited degree of renal escape from the
antidiuretic effects of DDAVP (urine osmolalities 800 to 1200 mOsm/kg
H20). Studies of brain water and electrolyte contents demonstrated
complete normalization of brain volume after 14 to 28 days of sustained
hypoosmolality, the major part of which (70%) could be accounted for
by loss of brain electrolytes. Both natriuresis and kaliuresis occurred
during the first five days of hypoosmolality, and were of sufficient
magnitude to suggest some degree of adaptation of other body fluid
compartments via electrolyte losses as well. These results indicate that
rats have substantial capacity to tolerate prolonged severe hypo-
osmolality with little morbidity and mortality as long as proper attention
is paid to their nutritional requirements, and provide further evidence
that brain volume regulation likely represents the major adaptive
mechanism that allows survival despite sustained hypoosmolality.
Hypoosmolality is the most common disorder of body fluid
and electrolyte balance encountered in the clinical practice of
medicine [1], with incidences ranging from 15 to 22% in both
acutely [2] and chronically [3] hospitalized patients. Various
studies have suggested that hypoosmolality is an important
cause of morbidity and mortality as well [4, 5], although more
recent studies have questioned the actual incidence of mortality
with this disorder [6]. Several studies have also suggested that
rapid correction of hypoosmolality may lead to neurological
deficits from brain myelinolysis in man, similar to the proven
production of such lesions by rapid correction of hypoosmolal-
ity in animals [7—12]. However, substantial uncertainty exists
concerning many of these issues [13, 14], to the point that it is
not yet clear whether, and under what circumstances, hypoos-
molality and subsequent changes in plasma osmolality cause
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cellular and tissue dysfunction and death. And although much is
known about cellular adaptation to hypoosmolar conditions in
vitro [15, 16], much still remains unknown about such adaptive
changes and their consequences for mammals in vivo [17].
Consequently, methods allowing maintenance of stable hypo-
osmolality for long periods of time in healthy noncatabolic
animals would be desirable to attempt to study some of these
questions.
Review of the various methods used to induce and maintain
hypoosmolality in previous studies suggests that for the most
part they did not produce results analogous to human disease
for several identifiable reasons. First, animals spontaneously
ingest water only in response to physiological needs. Conse-
quently, even in the presence of an antidiuretic agent, animals
with free access to food and water will not become hypoos-
molar because they decrease their water intake to amounts just
sufficient to balance insensible water losses [18]. To overcome
this, investigators have had to resort to forced intravenous or
intragastric administration of hypotonic fluids in dogs [19—21]
and rats [22] to achieve the desired positive water balance.
However, several problems have become apparent with the use
of such methods: (a) they are difficult to use for long-term
studies of large groups of animals because of the need to
maintain intravenous catheters and external infusion pumps, or
alternatively to administer several daily gavages of fluid; (b)
most of these studies have had to use large and potentially
unphysiologic amounts of hypotonic infusate in order to main-
tain hypoosmolality, far greater than the relative ingested
volumes in hypoosmolar human patients; (c) virtually all animal
models utilized to date have exhibited the phenomenon of renal
"escape" from the hydroosmotic effect of the antidiuretic agent
used, an effect which has been shown to be due to the volume
expansion produced by excess fluid administration [23]; and (d)
most animal models have exaggerated the degree of natriuresis
produced, again in large part because of the continued volume
expansion caused by excess fluid administration. An earlier
model of experimental hypoosmolality in the rat developed in
this laboratory overcame many of these problems by using
continuous subcutaneous infusions of the antidiuretic vasopres-
sin analogue l-deamino-[8-D-arginine] vasopressin (DDAVP)
via osmotic minipumps in rats with access to 5% dextrose
solution in the absence of food [18]. In this case, rats ingested
the dextrose solution as a source of calories, but did so in
limited amounts such that renal escape from antidiuresis did not
occur despite severe sustained hypoosmolality [18, 24]. Unfor-
tunately, this model tended to exacerbate yet another major
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problem frequently encountered with past animal models of
hypoosmolality, namely, production of a catabolic state that
limited the period of time during which the hypoosmolality
could be maintained. Production of tissue catabolism with large
amounts of weight loss has been a common finding in many
animal models of hypoosmolality because hypoosmolar animals
generally decrease food consumption, presumably as a mani-
festation of systemic illness. This effect not only contributes to
the morbidity and mortality of the experimental animals, but
also obviously complicates studies of cellular and tissue adap-
tation to hypoosmolar conditions in vivo. The occurrence of
ongoing catabolism is particularly worrisome in studies of
experimental myelinolysis because central pontine myelinolysis
in humans has also been frequently associated with malnutrition
in patients with chronic alcoholism [7, 10, 25]. It seems note-
worthy that previous studies of myelinolysis in experimental
animals have uniformly failed to consider this variable [9—12],
and consequently the potential role of caloric deficiency and
ongoing tissue catabolism in contributing to the brain lesions
produced remains conjectural.
This report describes the development and characterization
of a rat model of sustained hypoosmolality that eliminates or
minimizes the problems of excess fluid administration and
tissue catabolism, and allows convenient maintenance of hypo-
osmolality for long periods of time in relatively healthy animals
with stable body weights and negligible morbidity and mortal-
ity. Analysis of brain water and electrolyte contents following
prolonged hypoosmolality using these methods has revealed
normalization of brain water content, thus demonstrating the
ability of brain tissue in vivo to volume regulate completely in
response to hypoosmolality of sufficient duration.
Methods
Animals and maintenance
Male albino rats of the Sprague-Dawley strain (Zivic-Miller
Laboratories, Allison Park, Pennsylvania, USA) weighing 250
to 300 g were used for all studies. They were housed individu-
ally In wire mesh cages in a temperature-controlled room (21 to
23°C) with lights on from 7 a.m. to 7 p.m. All animals were
maintained on standard rat chow (Wayne Lab-Blox, Chicago,
Illinois, USA) and ad libitum tap water prior to initiation of the
protocol used to induce and maintain hypoosmolality.
Induction of hypoosmola/ity
Rats were first acclimated for three to four days to a com-
mercial, nutritionally-balanced liquid diet formulated for ro-
dents (AIN-76, Bio-Serv, Frenchtown, New Jersey, USA).
During this time they had access to tap water ad libitum, but no
other source of food. At the normal recommended dilution, this
formula supplies 1.0 kcallml consisting of 66% carbohydrate (as
maltose dextrins), 21% protein (as casein) and 12% fat (as corn
oil), along with vitamins and trace elements. Based on National
Research Council estimates of caloric requirements for mainte-
nance of body weight in adult rats (114 kcal/kg°75 [26]), approx-
imately 70 mI/day of this formula are required to maintain stable
body weight in 250 to 300 g rats, assuming an estimated 80%
efficiency of conversion of gross energy to metabolizable en-
ergy [26]. However, in order to decrease the water content of
the diet (69.1% by weight at the normal dilution) and thereby
reduce overhydration and renal escape from antidiuresis, the
dilution was modified as follows: 258 g of powdered formula
was blended with 520 ml of a solution of 14% dextrose in water
and stored at 4°C. This resulted in a formula with a caloric
density of 1.9 kcallrtil and a water content of only 57.3% by
weight. This modified concentrated formula was supplied to the
animals in 100 ml glass liquid feeding tubes (Bio-Serv Model
LDF-l 1) as a single morning feeding of 40 ml daily. This amount
therefore provided a caloric input of 75.6 kcallday with only
22.9 mI/day of water. Following three to four days of acclima-
tization to this diet, osmotic minipumps (Alzet model 2002, Palo
Alto, California, USA) containing DDAVP (Desmopressin Ac-
etate, 0.01% intranasal solution, USV Laboratories, Tarry-
town, New York, USA) dissolved in 0.15 M NaC1 at a concen-
tration of either 10 or 2 g/ml were implanted subcutaneously
along the back [18] under methoxyflurane inhalational anesthe-
sia. At these concentrations, DDAVP was infused at rates of 5
ng/hr and 1 ng/hr, respectively. After recovery from the anes-
thesia the rats were placed back in their cages with access to the
modified concentrated formula but without water bottles for the
remainder of the studies. In most cases the animals were
initially given 60 to 70 ml of the normal dilution (1.0 kcal/ml)
formula on the first day following pump insertion in order to
produce a positive water balance and hypoosmolality more
rapidly. On all subsequent days they were then given 40 ml/day
of the modified concentrated (1.9 kcallml) formula. For studies
lasting longer than two weeks, the DDAVP pumps were re-
placed under methoxyflurane anesthesia at 13 day intervals
(allowing one day for priming of the pump in 0.15 M NaC1 prior
to insertion).
Metabolic studies
For metabolic studies, rats were placed in individual plastic
metabolic cages (Nalgene model 650-0100, Rochester, New
York, USA) as described previously [18]. Three groups were
studied: control (infusion of vehicle, 0.15 M NaC1, only; N =
11), DDAVP infusion at 1 ng/hr (N = 12), and DDAVP infusion
at 5 ng/hr (N 11). Several days prior to the insertion of the
osmotic pumps, indwelling jugular venous catheters were in-
serted for drawing blood samples as also described previously
[271. The animals were weighed daily. Daily intakes of formula
were measured by weighing each feeding tube after filling with
formula, and then again the next morning to ascertain the total
amount consumed. Water content of the formula was deter-
mined by weighing an aliquot of each batch of formula used
before and after desiccation (72 hr at 150°C). For these studies,
this averaged 0.573 0.006 ml H20 per gram of concentrated
formula (mean of 30 determinations on 6 batches of formula).
Daily urine output was measured volumetrically. Measured
water balance was calculated as intake minus output, ignoring
insensible losses which were assumed to be constant for ani-
mals of similar weights housed under similar conditions [18].
Plasma samples (0.5 ml) were obtained for all animals on each
of the two days prior to insertion of the osmotic pumps, and on
days 1, 2, 3, 5, 10 and 13 following pump insertion. Red blood
cells were reinfused in an equivalent volume of 0.15 M NaCI
after each sample. After 13 days the osmotic pumps were
removed and the animals were followed for another two days on
the same formula intake. Additional blood samples were ob-
tained for all animals on each of the two days following pump
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removal. Plasma and urine sodium and potassium concentra-
tions were analyzed by ion-specific electrodes (Beckmann
Electrolyte II analyzer, Beckman Instruments, Fullerton, Cal-
ifornia, USA) and osmolalities by freezing point depression
(Advanced Instruments Osmometer). To determine the total
sodium and potassium intakes, aliquots of each batch of for-
mula used were weighed and then ashed (800°C for 6 hr), the
residues suspended in 0.75 M HNO3, and the sodium and
potassium concentrations measured as above. For these stud-
ies, these averaged 0.0262 0.0005 mEq Na and 0.0271
0.0004 mEq K per gram of concentrated formula (means of 30
determinations on 6 batches of formula). Net daily sodium and
potassium balances were calculated as the differences between
dietary intake and urine output (as in previous studies [18], fecal
electrolyte losses were assumed to be small and constant, and
were not analyzed).
An additional six rats were studied after three weeks of
sustained hypoosmolality to assess the effects of alteration of
the volume of formula ingested on urine concentration and
volume. For this study, jugular venous catheters were im-
planted on day 20 of sustained hypoosmolality (DDAVP infu-
sion rate = 5 ng/hr). After a two-day recovery period, the rats
were then placed in metabolic cages and followed as described
above. After two additional days of formula feedings of the
modified concentrated formula at 40 mllday, the rats were given
60 ml of the normal (1.0 kcalfml) diluted formula for two days
(water content = 0.691 0.003 ml H20 per gram of normal
dilution formula), and then finally 40 ml of the concentrated
formula again for two more days. This study allowed an
assessment of the effects of changes in water ingestion on urine
volume and osmolality during maintenance of equivalent caloric
intakes.
Brain water and electrolyte contents
Total brain water and electrolyte contents were measured
using standard methodologies [4, 28—33], as previously de-
scribed from this laboratory with minor modification [34].
Following decapitation the brains were rapidly dissected and
the entire forebrain rostral to the cerebellar-cortical junction
was weighed before and after desiccation (72 hr at 150°C). Total
brain water content was calculated as the difference between
the brain weights before and after desiccation, and expressed
per 100 g of dry brain weight (DBW). Following desiccation the
entire dried residue was placed in 10.0 ml of 0.75 M HNO3
for 72 hours at room temperature and then homogenized
(Brinkmann 1810 Tissue Homogenizer, Brinkman Instruments,
Westbury, New York). The homogenized brain was eluted for
an additional 48 hours at room temperature then centrifuged
(5,000 g for 60 mm). Na and K content of the supernatants
were determined by flame photometry (Beckman Klina Flame)
and C1 content by coulometric titration (Haake-Buchler Digi-
tal Chloridometer). All brain electrolyte contents were ex-
pressed per kg of dry brain weight. The above brain analyses
were done on a group of rats following maintenance of sus-
tained hypoosmolality for periods ranging from 14 to 28 days (N
= 25; mean days of sustained hypoosmolality 21 1) and
compared to identical brain analyses on a group of normona-
tremic control rats maintained on the same daily volume of the
liquid diet for an equivalent period (N = 18; mean days on liquid
diet 22 1).
Table 1. Plasma [Na1 of rats at the end of 2—5 week periods of
DDAVP infusion
.
Days of continuous
DDAVP infusion
DDAVP infusion rate
I nglhr 5 nglhr
14 115.9 1.2(N=17,d=0) 106.3 0.8(N=17,d=2)
15—21 113.1 0.9(N=51,d=0) 100.7 0.9(N=16,d=2)
22—28 116.5 0.8(N=63,d=0) 107.2 0.5(N=34,d=0)
29—35 111.7 1.3(N=3,d=0) 108.0 2.2(N=12,d=0)
All animals 115.0 0.6
(N = 134, d = 0)
104.5 1.4
(N = 79, d = 4)
Abbreviations are: N, number of rats successfully studied until
sacrifice in each group; d, number of rat deaths occurring before
sacrifice in each group; (plasma [Na] means include only rats that
survived until sacrifice).
The degree to which brain volume regulation in hypoosmolar
animals could be accounted for by measured losses of brain
electrolytes was estimated using calculations described in stud-
ies of acute hyponatremia [35]. Specifically, assuming osmotic
equilibrium between plasma and brain water after sustained
hypoosmolality, the change in osmotically-active brain solute
(SQ, in mOsmlkg DBW) that would have to occur to allow any
observed degree of volume regulation in the hypoosmolar brain
can be estimated by the formula:
LQ = [V1 X Cosm'] — [Vf x Cosm1 (1)
where V and Vf are the measured volumes of total brain water
(in mllkg DBW) before and after induction of hypoosmolality,
respectively, and Cosm1 and Cosm are the plasma osmolalities
(in mOsm/liter H20) before and after induction of hypoosmolal-
ity (because plasma [Na} was measured rather than plasma
osmolality for most of these studies and because Q is based
upon relative changes in osmolality, plasma osmolality was
simply estimated as 2 x plasma [Nat] for the purpose of this
calculation).
Statistical analysis
All values are means SEM. All P values were determined by
two-tailed Student's t-test for unpaired observations.
Results
Using the protocol described above for the induction and
maintenance of hypoosmolality, a total of 223 rats were studied
in this laboratory over the past two years. Of all rats studied,
only six, or 2.7%, failed to achieve significant hyponatremia
(arbitrarily defined as a plasma [Nat] less than 130 mEq/liter).
The final plasma [Nat] levels for the rats that successfully
achieved significant hyponatremia are shown in Table I divided
according to the length of time that the hyponatremia was
maintained for each of the two DDAVP infusion rates used (for
most studies plasma [Na] was used as an indicator of plasma
osmolality; measured basal plasma osmolalities were 226 I
mOsm/kg H20 in 62 of the animals infused at 5 ng/hr DDAVP
and 242 1 mOsm/kg H20 in 87 of the animals infused at 1
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FIg. 1. Weight changes in rats with sustained hypoosmolality com-
pared to normonatremic controls on the same formula. Weekly weights
were obtained for 193 of the 213 hyponatremic rats described in Table
I. Shown are the weights expressed as a percentage of the starting
weight (pre-DDAVP pump insertion) separately for rats infused with I
ng/hr (—) and 5 ng/hr (• •) of DDAVP. Also shown are the
weekly weights of normonatremjc control animals given the same daily
amounts of the same formula but without DDAVP infusion (----E).
Each point shows the mean SE of the number of rats shown in
parentheses (the numbers decrease with longer periods of hypoosmolal-
ity since studies varied in duration from 2—5 weeks).
ng/hr DDAVP, as compared to 288 1 mOsm/kg H20 in
normonatremic control rats). These studies therefore represent
a total of 4,628 rat days of severe hypoosmolality (mean plasma
[Nai of all animals = 111.6 0.5 mEq/liter). Only four rats
died during these combined studies, representing a mortality
rate of 1.8% of all rats that became hyponatremic. As shown in
Table 1, half of the deaths occurred within the first two weeks
of sustained hypoosmolality and all by the first three weeks.
Furthermore, all deaths occurred at the higher (5 ng/hr)
DDAVP infusion rate, which produced significantly lower
plasma [Nat] concentrations. No obvious morbidity was appar-
ent in the animals that did not die, insofar as could be judged by
the normal daily activities of rats (such as, feeding, ambulation,
exploratory behaviour, grooming, etc.).
Figure 1 shows a summary of the weight changes for 193 of
the 213 hyponatremic rats that were weighed at weekly inter-
vals during the course of these studies. Also shown are the
weights of 52 control rats fed equivalent amounts of the same
diet but allowed ad libitum access to water to prevent dehydra-
tion (plasma [Nat] 142.1 0.3 mEq/liter). All weights are
expressed as a fraction of the starting weight immediately prior
to DDAVP pump insertion. Rats infused with 5 nglhr of
DDAVP maintained a relatively steady weight slightly below
their starting weight, while those infused with 1 ng/hr of
DDAVP gained weight throughout the period of sustained
hypoosmolality at a rate equivalent to that of the normona-
tremic control rats given identical amounts of the same formula.
Figures 2 through 4 show the results of a metabolic study of
34 rats followed for two baseline days prior to insertion of
osmotic minipumps (days B1 and B2), 13 days following pump
insertion (days 1 to 13), and two additional days after removal
of the pumps (days 14 and 15). As shown in Figure 2A, the
DDAVP-infused rats quickly became hyponatremic after the
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first day of DDAVP infusion, and thereafter maintained a stable
degree of hypoosmolality until the DDAVP pumps were re-
moved on day 14, after which plasma [Nat] corrected to normal
levels within 24 to 48 hr. Animals receiving the higher (5 ng/hr)
DDAVP infusion rate maintained a plasma [Nat] approxi-
mately 10 mEq/liter below that of the animals receiving the
lower (1 ng/hr) infusion rate throughout the period of study,
similar to the cumulative results for all rats studied shown in
Table 1. As expected, urine osmolality remained elevated
relative to the control rats throughout the period of DDAVP
infusion (Fig. 2B). However, even though urine osmolalities
remained near 1000 mOsm/kg H20 for both DDAVP infusion
rates, a relative decrease in urine osmolality from very high
levels (1,800 to 2,000 mOsm/kg H20) to the range of 800 to 1200
mOsm/kg H20 clearly occurred over the first five to seven days
of DDAVP infusion. Analysis of the measured water balance
(water intake minus urine output) shown in Figure 2C demon-
strates the positive water balance at the start of the DDAVP
infusion, which produced the dilutional hyponatremia, as well
as the prompt water diuresis immediately following pump
removal, which resulted in correction of the osmolality. Be-
tween these two points relative water balance generally
occurred, with the differences between intake and output re-
flecting insensible water losses [181. Eventually this was equiv-
alent for both the controls and the DDAVP-infused rats, al-
though a period of negative water balance was observed during
days three through five in the animals receiving 5 ng/hr
DDAVP,
Figure 3A demonstrates that an initial weight gain accompa-
nied the water retention for both DDAVP-infused groups as
expected. However, over the next several days the weights of
the 5 ng/hr DDAVP infusion group then decreased and gradu-
ally returned to basal levels, after which they then remained
stable throughout the subsequent days of DDAVP infusion,
while those of 1 ng/hr infusion group increased at a rate
comparable to the normonatremic controls (again similar to the
cumulative results for all rats studied shown in Fig. 1). While
this might suggest excretion of the initially retained water, the
later rapid weight loss secondary to the diuresis following pump
removal on day 14 indicates that a dilutional hyponatremia from
excess water was still present at that time. Following the water
diuresis produced by pump removal, the weights of the 5 ng!hr
DDAVP-infused group decreased to approximately 12 to 15%
below starting weights, while the weights of the 1 ng/hrDDAVP
group decreased to levels nearly identical to their starting
weights. Figure 3B shows that during the first several days of
hyponatremia the DDA VP-infused rats did not eat the full 40 ml
of the liquid formula. This effect was most pronounced on days
three to five in the 5 ng/hr DDAVP infusion group, a period of
time which coincided with the decreases in body weight (Fig.
3A) and the negative water balance (Fig. 2C) in this group.
However, with gradual recovery of appetite rats in both
DDAVP-infused groups eventually consumed the total amount
of calories required for weight maintenance, similar to the
normonatremic control animals. Interestingly, on the first day
following pump removal all animals consumed the full 40 ml of
the liquid formula, but on the second day the 5 ng/hr DDAVP
infusion group consumed substantially less. No obvious motor
or other impairments were observed to account for the de-
creased food intake in this group at this time.
5
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Fig. 2. Plasma [Na], urineosmolality and
water balance during sustained
hypoosmolality. Shown are results from rats
infused with I ng/hr (A.-—-—, grey bars, N =
12) or 5 ng/hr of DDAVP (• •, solid bars,
N = II), as compared to control rats
receiving subcutaneous infusions of only 0.15
M NaCI via osmotic minipump (fl----D, open
bars, N = Il). Rats were followed in
metabolic cages for two baseline days prior to
osmotic minipump insertion (B1 and B2), then
for 13 days of either DDAVP or 0.15 M NaCI
infusion (days 1—13), and finally for 2
additional days after osmotic minipump
removal (days 14 and 15). All rats received
identical amounts of the same formula on
each day, but only the control rats also had
access to tap water drinking solution. A.
Plasma [Na1 levels (mEq/liter) obtained via
indwelling jugular venous catheters during the
course of the study. B. 24-Hour urine
osmolalities (mOsm/kg H20) obtained daily
throughout the course of the study. C.
24-Hour measured water balance (ml)
calculated as water content of ingested
formula (plus tap water for control rats) minus
urine output for each day of study. Results
shown are means SE.
Figures 4A and B show the net Na and K balances,
demonstrating significant natriuresis and kaliuresis, greater in
the 5 ng/hr DDAVP infusion group, until after the fifth day of
DDAVP infusion when relative balance was achieved for these
parameters as well. The greatest natriuresis always was seen on
day two, the day after water loading, in both DDAVP-infused
groups. Significant kaliuresis also occurred on this day, but was
far greater over days three through five in the 5 ng/hr DDAVP
group, coinciding with the period of maximally decreased
formula intake and weight loss in this group (Fig. 3).
Figure 5 demonstrates the changes in urine volume and
osmolality with different concentrations of the liquid formula.
On the modified concentrated formula at 40 mI/day, urine
osmolality averaged 1056 65 mOsm/kg H20 with urine
outputs of 12.7 0.8 mI/day and maintenance of plasma [Nat]
at 108 2 mEq/liter. Upon switching to 60 ml of the dilute
formula, urine volume increased to 32.2 3.1 mI/day while
urine osmolality decreased to 386 69 mOsm/kg H2O, coinci-
dent with a decrease in plasma [Nat] to 100 1 mEq/liter by
the second day of the dilute formula. Following reinstitution of
the smaller volume of concentrated formula, all parameters
reverted back toward the earlier values.
Table 2. Total brain water and electrolyte content of normonatremic
rats and rats with sustained hypoosmolality
Normonatremic
N= 18
HyponatremicN=25
Percent
change
Plasma [Naj 141 1 107 ia —24.1%
mEqiliter
Brain water 372.5 2.1 374.7 1.2 +0.6%
ml/100 g DBW
Brain K 502.2 14.6 415.2 5•9a —17.3%
mEq/kg DBW
Brain Na 274.5 6.1 244.3 l.8a —11.0%
mEq/kg DBW
Brain Cl 168.9 5.1 113.7 2.4a —32.7%
mEq/kg DBW
a P < 0.001 relative to normonatremic controls
Analysis of total brain water and electrolyte contents after 21
1 days of sustained hypoosmolality is shown in Table 2, in
comparison with identical brain analyses of a group of
normonatremic rats maintained on the same volume of liquid
diet for an equivalent period (22 1 days). The control values
for total brain water and electrolyte contents are similar to
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Fig. 3. Body weight and formula intake
during sustained hypoosmolality. Shown are
results from the same metabolic study
described in Figure 2. A. Daily weights
expressed as a percentage of starting weight
immediately prior to osmotic minipump
insertion (day B2). B. Daily intakes of formul
throughout the study (on day 1 all rats were
allowed access to 60 ml of the regular 1.0
kcal/ml formula; on all other days they were
allowed access to the more concentrated 1.9
kcal/ml formula). All symbols are as describe
in Figure 2.
Fig. 4. Na and K balances during
sustained hypoosmolality. Shown are the
results of the same metabolic study described
in Figure 2. For both Na and K the balanc
was calculated as the difference between
dietary intake and urinary losses, ignoring
fecal losses which were assumed to be small
and constant across groups. A. 24-Hour Na
balances calculated daily throughout the
study. B. 24-Hour K balances calculated
daily throughout the study. All symbols are a
described in Figure 2.
those reported in multiple previous studies [4, 28—35]. Despite
the 24.1% decrease in plasma [Na], total brain water content
of the hyponatremic animals was not significantly different from
the control group. However, significant decreases were mea-
sured in total brain K (—17.3%), Na (—11.0%) and Cl
(—32.7%) contents of the hyponatremic animals. Based o
equation (1), Q, the predicted change in osmotically activ
total brain solute to allow this degree of volume regulation
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Fig. 5. Effect of increased water intake on
urine osmolality and volume during sustained
hypoosmolality. Rats with indwelling jugular
venous catheters were placed in metabolic
cages after 21 days of DDAVP infusion (5
ng/hr). Following 2 days with access to 40
mi/day of the concentrated 1.9 kcal/ml
formula, they were given 60 mi/day of the
regular 1.0 kcal/ml formula for 2 days, and
then followed for 2 additional days on the
concentrated formula again. Shown are the
24-hour urine osmolalities (• •), the daily
urine volumes (•) and the plasma [Na]
levels (parentheses below days) for each of
the six study days. Results are means SE
for six rats.
gested fluids without significant renal escape from antidiuresis
or ongoing tissue catabolism and weight loss.
However, certain disadvantages are nonetheless still appar-
ent. First, some tissue catabolism does occur, especially at the
5 nglhr DDAVP infusion rate as indicated by the initial weight
loss over the first several days of hypoosmolality in this group.
While this then stabilizes for the remainder of the period of
DDAVP infusion, studies done during the first week using this
infusion rate must take into account the liklihood of ongoing
tissue catabolism during this time. Without taking this factor
into account it would be more difficult to explain some of the
results observed in the 5 ng/hr DDA VP-infused rats during the
first five days of the metabolic balance study shown in Figures
2 to 4. The coincidence of the significantly decreased formula
intake on days three to five with the weight loss, negative water
balance and urinary electrolyte losses during this period, de-
spite continued stable hyponatremia, can potentially be ex-
plained by the occurrence of tissue catabolism as a result of
decreased caloric intake; in this case, despite a decreased water
intake as well during this period, as reflected by the negative
measured water balances, spontaneous correction of the
hypoosmolality would not occur because of the added compo-
nent of endogenously-generated free water as a result of the
tissue catabolism [18]. Alternatively, maintenance of hypona-
tremia despite a decreased water intake during this period could
also be due to urinary electrolyte losses as a result of ECF and
ICF volume regulatory processes [18, 20], and the present data
do not allow a critical assessment of the relative contributions
of these two effects at this DDAVP infusion rate. On the other
hand, use of the lower 1 nglhr DDAVP infusion rate reduces or
eliminates this problem. As shown in Figure 1, animals main-
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would be 248.6 mOsm/kg DBW, a value substantially greater
than the sum of the experimentally observed decreases in
measured brain electrolytes (Na + zK + Cl = 172.4 mEq/kg
DBW, equivalent to 172.4 mOsm/kg DBW for monovalent
electrolytes).
Discussion
The studies summarized in this paper demonstrate the feasi-
bility of maintaining rats with severe degrees of hypoosmolality
for long periods of time. The use of a liquid diet in combination
with continuous subcutaneous administration of DDAVP by
osmotic minipump offers several advantages over previous
methods: (a) this model is very easy to use since the animals
spontaneously ingest their water loads, an important advantage
for long term studies of hypoosmolality in large numbers of
animals; (b) severe degrees of hypoosmolality can be produced
reliably; (c) the use of DDAVP allows evaluation of water
retention without potential vascular effects from the pressor
activity of vasopressin; (d) the animals remain healthy as
indicated by stable or increasing body weights and very low
rates of mortality despite long periods of hypoosmolality; (e)
the phenomenom of renal escape from the antidiuretic effects of
DDAVP can be minimized by limiting the animals' total fluid
intakes; and (1) the hypoosmolality is easily reversible simply
by removing the DDAVP minipumps. Consequently, this model
appears particularly well-suited for studies of chronic hypoos-
molality in rats, and should be easily adaptable for use in other
species as well. Furthermore, in many ways it better approxi-
mates human pathophysiology than have most previous meth-
ods, insofar as chronic hypoosmolality is maintained via in-
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tamed at this infusion rate continue to gain weight at a steady
rate, although most of the early weight gain probably represents
retained water since removal of the DDAVP pumps after 13
days of hypoosmolality results in an abrupt decrease in weight
back to the pre-infusion levels (Fig. 3A). Nonetheless, over
longer periods of sustained hypoosmolality true tissue weight
gain does occur in this group as shown in Figure 1. Elimination
of tissue catabolism at this DDAVP infusion rate therefore
allows a clearer interpretation of the observed urinary electro-
lyte losses (Fig. 4) as likely being secondary to volume regula-
tory processes rather than catabolic processes.
Secondly, while renal escape from the antidiuretic effect of
DDAVP is minimized, it is not absent as indicated by the
relative decrease in urine osmolality during the first several
days of the metabolic studies shown in Figure 2B. Nonetheless,
the ability to maintain urine osmolalities chronically in the
range of 800 to 1200 mOsm/kg H20 represents an improvement
over previous methods that resulted in greater degrees of renal
escape from antiduresis [19, 22]. In agreement with previous
studies [18], the 1 ng/hr infusion rate of DDAVP produced urine
osmolalities reasonably equivalent to the higher infusion rates,
although urine volumes tended to be somewhat higher with
achievement of correspondingly lesser degrees of hypoosmolal-
ity in this group (Table 1, Fig. 2A). The likelihood that the
degree of renal escape observed is related to the degree of
volume expansion in this model is shown in Figure 5, which
demonstrates induction of a greater degree of renal escape
simply by increasing the volume of the ingested formula.
Presumably, the mechanism causing renal escape under these
conditions is related to increased renal perfusion pressure,
similar to previous studies in dogs [23]. Theoretically, the urine
osmolalities in this model could be maintained even higher by
further reducing the volume of formula ingested, as long as the
total volume of water ingested remained equal to or greater than
the animals' insensible water losses [181. However, a practical
limit in this regard is that the liquid formula becomes too
viscous to flow through feeding tubes in concentrations much
above 1.9 kcallml. Although it may be possible to supplement a
smaller volume of the liquid diet with a measured amount of
solid food, preliminary trials using this method have not proved
to be as reliable in maintaining hypoosmolality because the
animals' liquid formula intake becomes much more unpredict-
able and variable when rats are offered even small amounts of
solid food.
In addition to describing a useful method for reliably main-
taining long-term hypoosmolality in rats, the present results
demonstrate that rats can adapt quite successfully to hypoos-
molar conditions. Previous studies in rabbits have clearly
demonstrated that the rapidity of development of severe
hypoosmolality is a major determinant of morbidity and mor-
tality in experimental animals [41. However, the deleterious
effects of sustained hypoosmolality once animals have success-
fully survived an initial decrease in plasma osmolality have not
been as well studied. Several recent studies have reported
mortality rates in hypoosmolar animals ranging from 30 to 60%
in rats, rabbits and dogs [10—12], but in these studies it has not
been clear whether the mortality was attributable to the hypo-
osmolality itself or to other factors, such as the nutritional
status of the animals. This question is relevant for issues of
human pathophysiology, since it has been frequently suggested
that severe hypoosmolality by itself carries a high risk of
mortality [4]. In this large study very little mortality was
observed despite achievement of degrees of hyponatremia
analogous to those of previous studies, which in addition was
maintained for longer periods of time than in previous studies.
Furthermore, all deaths occurred in the 5 ng/hr DDAVP infu-
sion group, in which some degree of weight loss and tissue
catabolism occurred. However, this group also maintained a
plasma [Na] significantly lower than the 1 ng/hr infusion group
and consequently it cannot be ascertained whether the catabolic
state of the rats or the more severe degree of hyponatremia, or
possibly the combination of the two, led to the small number of
deaths in this group. On the other hand, some studies have also
not noted high mortality rates with induction of acute hypona-
tremia in rats despite markedly catabolic states [18, 22], conse-
quently additional factors such as type of anesthesia employed
and the initial rate of fall of plasma [Na] could well have been
of greater importance in those studies where high mortality was
noted. While rat studies obviously cannot answer questions of
mortality during human disease, nonetheless the present results
demonstrate clearly that animals are able to adapt to hypoos-
molality with surprisingly little morbidity and mortality even
over relatively long periods of sustained severe decreases in
plasma osmolality.
The mechanism which allows survival of animals in the face
of chronic hypoosmolality of the extracellular fluid has long
been thought to be cellular volume regulation, by which cellular
dysfunction secondary to osmotic swelling is minimized or
prevented. In the brain this occurs predominantly via extrusion
of cellular solute, in large part potassium but undoubtedly other
intracellular solutes as well, as initially documented by the
studies of Yannet in the 1930's [28], and later verified by
multiple other investigators [4, 29—3 3]. Nonetheless, all of these
studies still showed some residual brain edema in hypoosmolar
animals, suggesting incomplete regulation of brain volume. The
present studies demonstrate that with sufficiently prolonged
hypoosmolality in otherwise healthy animals, complete brain
adaptation in fact occurs with eventual achievement of a brain
water content identical to normonatremic animals maintained
on the same diet. However, unlike in the case of acute dilutional
hypoosmolality, where monovalent brain electrolyte losses
were found to account for all the observed brain volume
regulation [35], only 69.3% of the brain volume regulation in
this study could be accounted for by such measured electrolyte
losses. Further analysis of this data reveals that virtually all
(94.3%) of the anticipated cationic losses (QI2, or 124.3
mOsmlkg DBW) could be accounted for by the measured brain
K and Na losses, whereas only 44.4% of the anticipated
anionic losses could be explained by Cl— losses. This is consis-
tent with the later stages of brain volume regulation during
chronic sustained hypoosmolality resulting primarily from
intracellular solute losses, for which K would be the major
decreased intracellular cationic solute, but other solutes (pro-
teins and amino acids [16, 17]) would likely make up a signifi-
cant portion of the decreased intracellular anionic solute. To
what degree cellular loss as opposed to osmotic inactivation or
sequestration of such non-electrolyte solute occurs in the brain
remains unanswered by these studies.
Similarly still unanswered is the degree to which other body
cells outside the brain are also able to volume regulate during
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chronic hypoosmolality. Earlier studies have suggested that
muscle tissue does not volume regulate to the same degree as
brain in response to hypoosmolality [30—32], but this has not
been reexamined systematically after longer periods of sus-
tained hypoosmolality. However, the probability that more
generalized solute loss is occurring in tissues other than the
brain is suggested by the metabolic balance studies shown in
Figure 4. In the 5 ng/hr DDAVP infusion group, the total
negative K balance over the first five days of sustained
hypoosmolality was —0.897 0.077 mEq/l00 g body wt, an
amount roughly equivalent to the negative Na balance, —0.821
0.094 mEq/l0O g body wt. The maximum amount of K
excretion which could be accounted for by brain volume
regulation based on the results shown in Table 2 is 12.9
mEq/l00 g DBW, or 0.013 mEq/l00 g body wt based on a mean
dry brain weight of 0.100 0.003 g/lOO g body wt, which
represents only 1.4% of the observed K secretion. However,
as discussed previously, significant tissue catabolism clearly
occurs during the first several days of sustained hypoosmolality
using this infusion rate, thereby resulting in probable overesti-
mation of the amount of K extrusion from cells as a means of
adaptation to chronic hypoosmolality. A more accurate sti-
mate of cellular volume regulation during sustained hypoos-
molality can be obtained from a similar analysis of the balance
data from the rats infused with DDAVP at 1 ng/hr. Although
this group gained approximately 10% total body weight over the
13 days of DDAVP infusion, most of this increase probably
represented retained water since following DDAVP pump re-
moval their weights abruptly decreased to levels identical to the
pre-DDAVP weights. Consequently, their K and Na bal-
ances likely more closely reflect adaptational changes rather
than the effects of tissue catabolism or anabolism. In this group,
the total negative K and Na balances over the first five days
of sustained hypoosmolality were —0.167 0.103 and —0.355
0.060 mEq/100 g body wt, respectively. These amounts were
both significantly less than were observed in the 5 nglhr infusion
group, suggesting that some proportion of the kaliuresis and
natriuresis observed in the higher DDAVP infusion group was
probably secondary to tissue catabolism rather than volume
regulation via solute loss (but because the 5 nglhr DDAVP
infusion group was more hyponatremic, it must be acknowl-
edged that a portion of the increased urinary electrolyte excre-
tion in this group might be expected on the basis of a greater
degree of solute loss as a result of volume regulation). None-
theless, the total amount of K excretion observed in the 1
nglhr infusion group, while more variable, still was greater than
that amount which would be predicted on the basis of brain
volume regulation alone (in this case 7.8% of the total K
excretion), again suggesting some degree of cellular volume
regulation by other body tissues as well. Most likely this
represents more limited degrees of volume regulation in non-
brain tissues, as has been suggested by in vitro studies of
different cell types [15, 161.
Finally, the complete adaptation of brain water content via
solute loss with prolonged hypoosmolality may also be of
importance to the question of myelinolysis with subsequent
correction of hypoosmolality. While most studies of experimen-
tal myelinolysis following increases in osmolality in hypoos-
molar animals have appropriately emphasized the importance
of the magnitude and the rate of increases in plasma osmolality
in producing the lesions [9—121, two studies have suggested that
chronicity of the preexisting hypoosmolality may be an impor-
tant pathogenetic factor as well [12, 36]. The results of the
present study suggest a mechanism whereby this might occur,
since with longer duration of sustained hypoosmolality more
complete brain adaptation occurs through greater losses of total
brain solute. Because subsequent increases in plasma osmolal-
ity dehydrate the brains of hypoosmolar animals [34], this effect
might be even more pronounced in animals with more chronic
hypoosmolality and consequently less total brain solute with
which to buffer the subsequent increases in plasma osmolality.
However, even if this mechanism did result in increased sus-
ceptibility of the brains of chronically hypoosmolar animals to
osmotic dehydration and possibly myelinolysis, an obvious
limit on the degree of increased susceptibility would be reached
by the time complete brain volume regulation had occurred,
since there would be no ongoing stimulus to further brain solute
losses beyond this point.
In summary, the very low morbidity and mortality rates
observed using these methods in large groups of animals
demonstrate that, at least in the rat, hypoosmolality itself does
not appear to be particularly deleterious to cellular and tissue
viability. We therefore anticipate that use of this model in future
investigations should enable a better understanding of cellular
and tissue adaptation to chronic hypoosmolality in vivo,
thereby hopefully enhancing our understanding of the patho-
physiological mechanisms involved in human hypoosmolar
states as well.
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